Page last updated: 2024-08-21

oxazoles and enalaprilat anhydrous

oxazoles has been researched along with enalaprilat anhydrous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Erdös, EG; Marcic, BM	1

Other Studies

1 other study(ies) available for oxazoles and enalaprilat anhydrous

Article	Year
Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin. The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Bradykinin; Bradykinin Receptor Antagonists; Calcium; Cells, Cultured; CHO Cells; Cricetinae; Drug Interactions; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Humans; Marine Toxins; Naphthalenes; Okadaic Acid; Oxazoles; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Kinase C; Pulmonary Artery; Receptor, Bradykinin B2; Receptors, Bradykinin; Transfection	2000

Article

Year

Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.

The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:2

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arachidonic Acid; Bradykinin; Bradykinin Receptor Antagonists; Calcium; Cells, Cultured; CHO Cells; Cricetinae; Drug Interactions; Enalaprilat; Endothelium, Vascular; Enzyme Inhibitors; Humans; Marine Toxins; Naphthalenes; Okadaic Acid; Oxazoles; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Kinase C; Pulmonary Artery; Receptor, Bradykinin B2; Receptors, Bradykinin; Transfection

2000